Will V940 get approval from the FDA for lung cancer?
5
Ṁ70Ṁ1812030
91%
chance
1H
6H
1D
1W
1M
ALL
V940-002 is a personalized cancer vaccine (Moderna) + pembrolizumab (Merck). The trial (link) is on patients with resected non small cell lung cancer. Will it pass phase 3 and get approval?
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000Sort by:
The trial I linked to is for lung cancer, but V940 is in several other trials as well (see e.g. this press release) - I'm inclined to resolve YES if any of them get approval (and would have said so when I made this market), but I realize it's very old so if anyone objects to me changing the criteria now say so.
People are also trading
Related questions
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
5% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
13% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
19% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
26% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will dt120 get fda approval before 2029
61% chance
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
30% chance